Literature DB >> 22465009

Ligand structural motifs can decouple glucocorticoid receptor transcriptional activation from target promoter occupancy.

Raymond D Blind1, Inés Pineda-Torra, Yong Xu, H Eric Xu, Michael J Garabedian.   

Abstract

Glucocorticoid (GC) induction of the tyrosine aminotransferase (TAT) gene by the glucocorticoid receptor (GR) is a classic model used to investigate steroid-regulated gene expression. Classic studies analyzing GC-induction of the TAT gene demonstrated that despite having very high affinity for GR, some steroids cannot induce maximal TAT enzyme activity, but the molecular basis for this phenomenon is unknown. Here, we used RT-PCR and chromatin immunoprecipitation to determine TAT mRNA accumulation and GR recruitment to the TAT promoter (TAT-GRE) in rat hepatoma cells induced by seven GR ligands: dexamethasone (DEX), cortisol (CRT), corticosterone (CCS), 11-deoxycorticosterone (DOC), aldosterone (ALD), progesterone (PRG) and 17-hydroxyprogesterone (17P). As expected, DEX, CRT, CCS and ALD all induced both TAT mRNA and GR recruitment to the TAT-GRE, while PRG and 17P did not. However, while DOC could not induce significant TAT mRNA, it did induce robust GR occupancy of the TAT-GRE. DOC also induced recruitment of the histone acetyltransferase p300 to the TAT-GRE as efficiently as DEX. These DOC-induced effects recapitulated at another GR target gene (sulfonyltransferase 1A1), and DOC also failed to promote the multiple changes in gene expression required for glucocorticoid-dependent 3T3-L1 adipocyte differentiation. Structural simulations and protease sensitivity assays suggest that DOC and DEX induce different conformations in GR. Thus, although steroids that bind GR with high affinity can induce GR and p300 occupancy of target promoters, they may not induce a conformation of GR capable of activating transcription.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22465009      PMCID: PMC3340612          DOI: 10.1016/j.bbrc.2012.03.084

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  33 in total

Review 1.  In vivo analysis of the model tyrosine aminotransferase gene reveals multiple sequential steps in glucocorticoid receptor action.

Authors:  T Grange; L Cappabianca; M Flavin; H Sassi; H Thomassin
Journal:  Oncogene       Date:  2001-05-28       Impact factor: 9.867

2.  Designer glucocorticoids.

Authors:  Jeffrey N Miner
Journal:  Biochem Pharmacol       Date:  2002-08-01       Impact factor: 5.858

3.  The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain.

Authors:  R M Nissen; K R Yamamoto
Journal:  Genes Dev       Date:  2000-09-15       Impact factor: 11.361

Review 4.  Novel glucocorticoid receptor coactivator effector mechanisms.

Authors:  B D Jenkins; C B Pullen; B D Darimont
Journal:  Trends Endocrinol Metab       Date:  2001-04       Impact factor: 12.015

5.  Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones.

Authors:  I Rogatsky; K A Zarember; K R Yamamoto
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

6.  Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription.

Authors:  Y Shang; X Hu; J DiRenzo; M A Lazar; M Brown
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

7.  Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor.

Authors:  David Masiello; Shinta Cheng; Glenn J Bubley; Michael L Lu; Steven P Balk
Journal:  J Biol Chem       Date:  2002-05-15       Impact factor: 5.157

8.  Formation of the androgen receptor transcription complex.

Authors:  Yongfeng Shang; Molly Myers; Myles Brown
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

Review 9.  The glucocorticoid receptor: coding a diversity of proteins and responses through a single gene.

Authors:  Matthew R Yudt; John A Cidlowski
Journal:  Mol Endocrinol       Date:  2002-08

Review 10.  p300/CBP proteins: HATs for transcriptional bridges and scaffolds.

Authors:  H M Chan; N B La Thangue
Journal:  J Cell Sci       Date:  2001-07       Impact factor: 5.285

View more
  3 in total

Review 1.  Structural analyses of inositol phosphate second messengers bound to signaling effector proteins.

Authors:  Raymond D Blind
Journal:  Adv Biol Regul       Date:  2019-10-11

Review 2.  Signaling through non-membrane nuclear phosphoinositide binding proteins in human health and disease.

Authors:  Jamal M Bryant; Raymond D Blind
Journal:  J Lipid Res       Date:  2018-09-10       Impact factor: 5.922

3.  The nature of the GRE influences the screening for GR-activity enhancing modulators.

Authors:  Karen Dendoncker; Steven Timmermans; Kelly Van Looveren; Lode De Cauwer; Karolien De Bosscher; Claude Libert
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.